Intervertebral Disk Degeneration
Conditions
Keywords
Degenerative disc disease, P-15 Bone Putty, Bone graft, Cervical discectomy, Cervical spine
Brief summary
The aim of this trial is to evaluate if P-15 bone putty (investigational device) is not inferior in effectiveness and safety to local autologous bone (control device) when applied in instrumented anterior cervical discectomy and fusion (ACDF) with use of a structural allograft ring in patients with degenerative cervical disc disease..
Detailed description
Anterior Cervical Discectomy and Fusion (ACDF) is a common surgical treatment option for symptomatic degenerative cervical disk disease in patients who fail conservative treatment. i-FACTOR bone graft is a unique anorganic bone mineral (ABM) and small peptide, P-15™. P-15 is a synthetic fifteen amino acid polypeptide that mimics the cell-binding domain of Type I human collagen and is responsible for osteogenic cell attachment via alpha2-beta1 integrins. This is randomized, controlled, multi-center, prospective FDA IDE study conducted to assess the safety and effectiveness of i-FACTOR bone graft (Cerapedics, Inc. Westminster, CO) in patients treated with single level ACDF. Patients received i-FACTOR bone graft or local autologous bone inside a structural allograft.
Interventions
Safety and efficacy of synthetic bone substitute used for fusion in spinal surgery
Local autologous bone will be harvested, milled and placed into the cavity of the structural allograft ring
Sponsors
Study design
Eligibility
Inclusion criteria
* Age between 18 and 65 * Radiographically determined discogenic origin to include at least one of the following characteristics: degenerated/dark disc on MRI, decreased disc height compared to adjacent levels on radiographic film, CT, or MRI and disc herniation on CT or MRI * Radicular symptoms by history and physical exam to include at least the following characteristics: Arm/shoulder pain, decreased flexes, decreased strength and abnormal sensation * Pain level arm/shoulder \>4 on 0-10 VAS * Pain level neck \>4 on 0-10 VAS * Neck disability Index \>30 * Involved discs between C3 and C7 * Undergoing anterior cervical fusion at a single level * Failed to gain adequate relief from non-operative treatment * Able and willing to give consent to participate in study * Understand and read English at elementary level
Exclusion criteria
Systemic infection such as AIDS, HIV, and active hepatitis; Significant metabolic disease that in the surgeon's opinion might compromise bone growth such as osteoporosis or osteomalacia; Taking medication for the prevention of osteoporosis; Circulatory, cardiac, or pulmonary problems that could cause excessive surgical risk; Active malignancy; Nondiscogenic source of symptoms (e.g., tumor, etc.); Multiple level symptomatic degenerative disc disease; Previous cervical fusion; Previous cervical decompression at the same level; Acute cervical trauma or instability (i.e., subluxation \> 3 mm on flexion/extension radiographic film); Undergoing treatment for tumor or bony traumatic injury to the cervical spine; Rheumatoid disease of the cervical spine; Myelopathy; Pregnant or planning to become pregnant in the next 2 years; Posterior cervical spine procedure scheduled; More than one level to be operated; Has a history of substance abuse (recreational drugs, alcohol); Is a prisoner; Is currently involved in a study of another investigational product for similar purpose; Has a disease process that would preclude accurate evaluation (e.g., neuromuscular disease, significant psychiatric disease).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Radiologic Fusion | 12 months | Successful fusion was based on roentgenographic examination showing: evidence of bridging trabecular bone between the involved motion segments, translational motion \<3mm, and angular motion \<5 degrees. If there was a lack of evidence of fusion on 12 month plain x-ray examination, a CT-scan was performed and final determination of the fusion status was made using the CT reading. The criteria for fusion on CT scans were: trabecular bone formation patterns within the intervertebral disc space and bridging bone formation that crosses the interspace. |
| Change in of the Overall Neck Disability Index (NDI) Score From Baseline. | 12 months | The NDI consists of ten items addressing functional activities (personal care, lifting, reading, work, driving, sleeping, recreational activities), pain intensity, concentration and headache. For each item, there are six potential responses, describing increasing degrees of disability (no disability = 0 to total disability = 5). An overall NDI score, out of 100, is calculated by adding up the scores for each item and multiplying by two. A higher NDI score indicates greater disability. |
| Neurologic Success | 12 months | The neurological endpoint is a binary variable. Neurologic success was assessed in the motor, sensory and reflex domains specific for the cervical spine as follows: maintenance or improvement of motor function in the elbow flexors (i.e. biceps muscle), elbow extensors (i.e. triceps muscle) and wrist extensors of both arms; maintenance or improvement of sensory function of both arms; maintenance or improvement of reflexes of both arms as measured at biceps tendon, triceps tendon and brachioradialis (supinator) reflex AND absence of Babinski reflex (if not present prior to surgery). Worsening of neurological status (neurological failure) was defined as a permanent decline in the subject's neurological status based on adjudication of accumulated neurological data by an independent blinded evaluator. |
| Complications | 12 months | Any AE within 12 months of surgery. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mean Change in the Short Form 36 v2 (SF-36v2) Mental Health Composite Score (MCS). | Baseline and 12 months | The SF-36 v2 (Medical Outcomes Trust, Boston, MA) is a multipurpose, patient-reported short-form health survey with 36 questions available in several languages. It yields two composite scores: one for physical health (Physical Composite Score - PCS) and one for mental health (Mental Composite Score - MCS) that are comprised of eight domains. The following domains make up the MCS: vitality, social functioning, role-emotional, mental health. The MCS ranges from a score of 0 (lowest possible level of functioning) to a score of 100 (highest possible level of functioning). |
| Mean Change in Pain at Neck Visual Analog Scale (VAS). | Baseline and 12 months | The pain VAS is a continuous scale upon which the subject indicates their pain level ranging from No pain at all (0) to Worst imaginable pain (10). The change in pain is calculated by subtracting the 12 month score from the baseline score. |
| Kyphosis | 12 months | Kyphosis is evaluated in degrees. |
| Mean Change at Pain at Arm and Shoulder Visual Analog Scale (VAS). | Baseline and 12 months | The pain VAS is a continuous scale upon which the subject indicates their pain level ranging from No pain at all (0) to Worst imaginable pain (10). The change in pain is calculated by subtracting the 12 month score from the baseline score. |
| Success Rates Measured by Aggregated Modified Odom's Criteria | 12 months | Subjects selected one of four categories: Excellent (Improvement Greater than or Equal to 80%, Deterioration Less than 10%), Good (Improvement Greater than or Equal to 70%, Deterioration Less than 15%), Fair (Improvement Greater than or Equal to 50%, Deterioration Less than 20%) or Poor (Improvement Less than 50%, Deterioration Greater than 20%). |
| Mean Change in the Short Form 36 v2 (SF-36v2) Physical Composite Score (PCS). | Baseline and 12 months | The SF-36 v2 (Medical Outcomes Trust, Boston, MA) is a multipurpose, patient-reported short-form health survey with 36 questions available in several languages. It yields two composite scores: one for physical health (Physical Composite Score - PCS) and one for mental health (Mental Composite Score - MCS) that are comprised of eight domains. The following domains make up the PCS: physical functioning, role-physical, bodily pain, general health. The PCS ranges from a score of 0 (lowest possible level of functioning) to a score of 100 (highest possible level of functioning). |
Countries
Canada, United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Bone Graft Substitute Subjects will receive anterior cervical discectomy with fusion and instrumentation (anterior plate). Structural allograft ring will be used. The cavity of the ring will be filled with P-15 synthetic osteoconductive bone substitute (investigational device).
P-15 Synthetic osteoconductive bone substitute: Safety and efficacy of synthetic bone substitute used for fusion in spinal surgery | 165 |
| Autologous Bone Subjects will receive anterior cervical discectomy with fusion and instrumentation (anterior plate). Structural allograft ring will be used. The cavity of the ring will be filled with local autologous bone.
Autologous bone: Local autologous bone will be harvested, milled and placed into the cavity of the structural allograft ring | 154 |
| Total | 319 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to Follow-up | 17 | 8 |
| Overall Study | Missed 12 Month Visit | 7 | 4 |
| Overall Study | Withdrawal by Subject | 2 | 1 |
Baseline characteristics
| Characteristic | Bone Graft Substitute | Total | Autologous Bone |
|---|---|---|---|
| Age, Continuous | 47.7 years STANDARD_DEVIATION 9.7 | 46.8 years STANDARD_DEVIATION 9.6 | 45.7 years STANDARD_DEVIATION 9.4 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 7 Participants | 11 Participants | 4 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 157 Participants | 307 Participants | 150 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 1 Participants | 1 Participants | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 1 Participants | 1 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 4 Participants | 5 Participants | 1 Participants |
| Race (NIH/OMB) Black or African American | 5 Participants | 11 Participants | 6 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 4 Participants | 7 Participants | 3 Participants |
| Race (NIH/OMB) White | 151 Participants | 295 Participants | 144 Participants |
| Region of Enrollment Canada | 29 participants | 55 participants | 26 participants |
| Region of Enrollment United States | 136 participants | 264 participants | 128 participants |
| Sex: Female, Male Female | 95 Participants | 192 Participants | 97 Participants |
| Sex: Female, Male Male | 70 Participants | 127 Participants | 57 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 136 / 165 | 128 / 154 |
| serious Total, serious adverse events | 45 / 165 | 35 / 154 |
Outcome results
Change in of the Overall Neck Disability Index (NDI) Score From Baseline.
The NDI consists of ten items addressing functional activities (personal care, lifting, reading, work, driving, sleeping, recreational activities), pain intensity, concentration and headache. For each item, there are six potential responses, describing increasing degrees of disability (no disability = 0 to total disability = 5). An overall NDI score, out of 100, is calculated by adding up the scores for each item and multiplying by two. A higher NDI score indicates greater disability.
Time frame: 12 months
Population: Per protocol (PP) subjects were included in this analysis. Six subjects that had major protocol deviations with the potential to impact the primary endpoint results were not included in the PP population.
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| Bone Graft Substitute | Change in of the Overall Neck Disability Index (NDI) Score From Baseline. | 28.75 units on a scale |
| Autologous Bone | Change in of the Overall Neck Disability Index (NDI) Score From Baseline. | 27.40 units on a scale |
Complications
Any AE within 12 months of surgery.
Time frame: 12 months
Population: All enrolled subjects.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Bone Graft Substitute | Complications | Yes | 138 participants |
| Bone Graft Substitute | Complications | No | 27 participants |
| Autologous Bone | Complications | Yes | 127 participants |
| Autologous Bone | Complications | No | 27 participants |
Neurologic Success
The neurological endpoint is a binary variable. Neurologic success was assessed in the motor, sensory and reflex domains specific for the cervical spine as follows: maintenance or improvement of motor function in the elbow flexors (i.e. biceps muscle), elbow extensors (i.e. triceps muscle) and wrist extensors of both arms; maintenance or improvement of sensory function of both arms; maintenance or improvement of reflexes of both arms as measured at biceps tendon, triceps tendon and brachioradialis (supinator) reflex AND absence of Babinski reflex (if not present prior to surgery). Worsening of neurological status (neurological failure) was defined as a permanent decline in the subject's neurological status based on adjudication of accumulated neurological data by an independent blinded evaluator.
Time frame: 12 months
Population: The total number of observed subjects.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Bone Graft Substitute | Neurologic Success | Yes | 134 participants |
| Bone Graft Substitute | Neurologic Success | No | 9 participants |
| Autologous Bone | Neurologic Success | Yes | 133 participants |
| Autologous Bone | Neurologic Success | No | 10 participants |
Radiologic Fusion
Successful fusion was based on roentgenographic examination showing: evidence of bridging trabecular bone between the involved motion segments, translational motion \<3mm, and angular motion \<5 degrees. If there was a lack of evidence of fusion on 12 month plain x-ray examination, a CT-scan was performed and final determination of the fusion status was made using the CT reading. The criteria for fusion on CT scans were: trabecular bone formation patterns within the intervertebral disc space and bridging bone formation that crosses the interspace.
Time frame: 12 months
Population: All participants that have radiological data at 12 months including imputed data.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Bone Graft Substitute | Radiologic Fusion | Fused | 129 participants |
| Bone Graft Substitute | Radiologic Fusion | No Evidence of Fusion | 16 participants |
| Autologous Bone | Radiologic Fusion | Fused | 121 participants |
| Autologous Bone | Radiologic Fusion | No Evidence of Fusion | 20 participants |
Kyphosis
Kyphosis is evaluated in degrees.
Time frame: 12 months
Population: Per protocol (PP) subjects who had images available at 12 months were included in this analysis. Six subjects that had major protocol deviations with the potential to impact the primary endpoint results were not included in the PP population.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Bone Graft Substitute | Kyphosis | 3.0 degrees | Standard Deviation 5 |
| Autologous Bone | Kyphosis | 3.8 degrees | Standard Deviation 4.9 |
Mean Change at Pain at Arm and Shoulder Visual Analog Scale (VAS).
The pain VAS is a continuous scale upon which the subject indicates their pain level ranging from No pain at all (0) to Worst imaginable pain (10). The change in pain is calculated by subtracting the 12 month score from the baseline score.
Time frame: Baseline and 12 months
Population: Per protocol (PP) subjects were included in this analysis. Six subjects that had major protocol deviations with the potential to impact the primary endpoint results were not included in the PP population.
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Bone Graft Substitute | Mean Change at Pain at Arm and Shoulder Visual Analog Scale (VAS). | 4.89 cm |
| Autologous Bone | Mean Change at Pain at Arm and Shoulder Visual Analog Scale (VAS). | 4.85 cm |
Mean Change in Pain at Neck Visual Analog Scale (VAS).
The pain VAS is a continuous scale upon which the subject indicates their pain level ranging from No pain at all (0) to Worst imaginable pain (10). The change in pain is calculated by subtracting the 12 month score from the baseline score.
Time frame: Baseline and 12 months
Population: Per protocol (PP) subjects were included in this analysis. Six subjects that had major protocol deviations with the potential to impact the primary endpoint results were not included in the PP population.
| Arm | Measure | Value (MEAN) |
|---|---|---|
| Bone Graft Substitute | Mean Change in Pain at Neck Visual Analog Scale (VAS). | 4.45 cm |
| Autologous Bone | Mean Change in Pain at Neck Visual Analog Scale (VAS). | 4.39 cm |
Mean Change in the Short Form 36 v2 (SF-36v2) Mental Health Composite Score (MCS).
The SF-36 v2 (Medical Outcomes Trust, Boston, MA) is a multipurpose, patient-reported short-form health survey with 36 questions available in several languages. It yields two composite scores: one for physical health (Physical Composite Score - PCS) and one for mental health (Mental Composite Score - MCS) that are comprised of eight domains. The following domains make up the MCS: vitality, social functioning, role-emotional, mental health. The MCS ranges from a score of 0 (lowest possible level of functioning) to a score of 100 (highest possible level of functioning).
Time frame: Baseline and 12 months
Population: Per protocol (PP) subjects were included in this analysis. Six subjects that had major protocol deviations with the potential to impact the primary endpoint results were not included in the PP population.
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| Bone Graft Substitute | Mean Change in the Short Form 36 v2 (SF-36v2) Mental Health Composite Score (MCS). | 8.33 score on a scale |
| Autologous Bone | Mean Change in the Short Form 36 v2 (SF-36v2) Mental Health Composite Score (MCS). | 8.21 score on a scale |
Mean Change in the Short Form 36 v2 (SF-36v2) Physical Composite Score (PCS).
The SF-36 v2 (Medical Outcomes Trust, Boston, MA) is a multipurpose, patient-reported short-form health survey with 36 questions available in several languages. It yields two composite scores: one for physical health (Physical Composite Score - PCS) and one for mental health (Mental Composite Score - MCS) that are comprised of eight domains. The following domains make up the PCS: physical functioning, role-physical, bodily pain, general health. The PCS ranges from a score of 0 (lowest possible level of functioning) to a score of 100 (highest possible level of functioning).
Time frame: Baseline and 12 months
Population: Per protocol (PP) subjects were included in this analysis. Six subjects that had major protocol deviations with the potential to impact the primary endpoint results were not included in the PP population.
| Arm | Measure | Value (LEAST_SQUARES_MEAN) |
|---|---|---|
| Bone Graft Substitute | Mean Change in the Short Form 36 v2 (SF-36v2) Physical Composite Score (PCS). | 10.02 units on a scale |
| Autologous Bone | Mean Change in the Short Form 36 v2 (SF-36v2) Physical Composite Score (PCS). | 9.95 units on a scale |
Success Rates Measured by Aggregated Modified Odom's Criteria
Subjects selected one of four categories: Excellent (Improvement Greater than or Equal to 80%, Deterioration Less than 10%), Good (Improvement Greater than or Equal to 70%, Deterioration Less than 15%), Fair (Improvement Greater than or Equal to 50%, Deterioration Less than 20%) or Poor (Improvement Less than 50%, Deterioration Greater than 20%).
Time frame: 12 months
Population: Per protocol (PP) subjects that had data available at the 12 month visit were included in this analysis. Six subjects that had major protocol deviations with the potential to impact the primary endpoint results were not included in the PP population.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Bone Graft Substitute | Success Rates Measured by Aggregated Modified Odom's Criteria | Excellent: Improvement GE 80% Deterioration LT 10% | 80 participants |
| Bone Graft Substitute | Success Rates Measured by Aggregated Modified Odom's Criteria | Good: Improvement GE 70% Deterioration LT 15% | 25 participants |
| Bone Graft Substitute | Success Rates Measured by Aggregated Modified Odom's Criteria | Fair: Improvement GE 50% Deterioration LT 20% | 16 participants |
| Bone Graft Substitute | Success Rates Measured by Aggregated Modified Odom's Criteria | Poor: Improvement LT 50% Deterioration GT 20% | 8 participants |
| Autologous Bone | Success Rates Measured by Aggregated Modified Odom's Criteria | Poor: Improvement LT 50% Deterioration GT 20% | 9 participants |
| Autologous Bone | Success Rates Measured by Aggregated Modified Odom's Criteria | Excellent: Improvement GE 80% Deterioration LT 10% | 80 participants |
| Autologous Bone | Success Rates Measured by Aggregated Modified Odom's Criteria | Fair: Improvement GE 50% Deterioration LT 20% | 15 participants |
| Autologous Bone | Success Rates Measured by Aggregated Modified Odom's Criteria | Good: Improvement GE 70% Deterioration LT 15% | 25 participants |